| Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-κB-dependent manner N Erez, M Truitt, P Olson, D Hanahan Cancer cell 17 (2), 135-147, 2010 | 1668 | 2010 |
| The dark side of fibroblasts: cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment L Monteran, N Erez Frontiers in immunology 10, 475160, 2019 | 559 | 2019 |
| Activated p53 suppresses the histone methyltransferase EZH2 gene X Tang, M Milyavsky, I Shats, N Erez, N Goldfinger, V Rotter Oncogene 23 (34), 5759-5769, 2004 | 251 | 2004 |
| Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1 N Cohen, O Shani, Y Raz, Y Sharon, D Hoffman, L Abramovitz, N Erez Oncogene 36 (31), 4457-4468, 2017 | 247 | 2017 |
| Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response JC Pahler, S Tazzyman, N Erez, YY Chen, C Murdoch, H Nozawa, ... Neoplasia 10 (4), 329-IN2, 2008 | 246 | 2008 |
| NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis N Ershaid, Y Sharon, H Doron, Y Raz, O Shani, N Cohen, L Monteran, ... Nature communications 10 (1), 4375, 2019 | 227 | 2019 |
| Bone marrow–derived fibroblasts are a functionally distinct stromal cell population in breast cancer Y Raz, N Cohen, O Shani, RE Bell, SV Novitskiy, L Abramovitz, C Levy, ... Journal of Experimental Medicine 215 (12), 3075-3093, 2018 | 213 | 2018 |
| p53-dependent down-regulation of telomerase is mediated by p21waf1 I Shats, M Milyavsky, X Tang, P Stambolsky, N Erez, R Brosh, I Kogan, ... Journal of Biological Chemistry 279 (49), 50976-50985, 2004 | 201 | 2004 |
| Melanoma miRNA trafficking controls tumour primary niche formation S Dror, L Sander, H Schwartz, D Sheinboim, A Barzilai, Y Dishon, ... Nature cell biology 18 (9), 1006-1017, 2016 | 200 | 2016 |
| Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors N Erez, S Glanz, Y Raz, C Avivi, I Barshack Biochemical and biophysical research communications 437 (3), 397-402, 2013 | 200 | 2013 |
| Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype M Milyavsky, I Shats, N Erez, X Tang, S Senderovich, A Meerson, ... Cancer research 63 (21), 7147-7157, 2003 | 189 | 2003 |
| From sentinel cells to inflammatory culprits: cancer‐associated fibroblasts in tumour‐related inflammation C Servais, N Erez The Journal of pathology 229 (2), 198-207, 2013 | 186 | 2013 |
| Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators J Conniot, A Scomparin, C Peres, E Yeini, S Pozzi, AI Matos, R Kleiner, ... Nature nanotechnology 14 (9), 891-901, 2019 | 167 | 2019 |
| Cancer-associated fibroblasts in the single-cell era D Lavie, A Ben-Shmuel, N Erez, R Scherz-Shouval Nature cancer 3 (7), 793-807, 2022 | 161 | 2022 |
| The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA H Offer, N Erez, I Zurer, X Tang, M Milyavsky, N Goldfinger, V Rotter Carcinogenesis 23 (6), 1025-1032, 2002 | 161 | 2002 |
| Tumor-derived osteopontin reprograms normal mammary fibroblasts to promote inflammation and tumor growth in breast cancer Y Sharon, Y Raz, N Cohen, A Ben-Shmuel, H Schwartz, T Geiger, N Erez Cancer research 75 (6), 963-973, 2015 | 155 | 2015 |
| Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1α activation and inhibits tumor growth N Erez, M Milyavsky, R Eilam, I Shats, N Goldfinger, V Rotter Cancer research 63 (24), 8777-8783, 2003 | 128 | 2003 |
| Control variable classification, modeling and anomaly detection in Modbus/TCP SCADA systems N Erez, A Wool International Journal of Critical Infrastructure Protection 10, 59-70, 2015 | 126 | 2015 |
| Astrocytes facilitate melanoma brain metastasis via secretion of IL‐23 A Klein, H Schwartz, O Sagi‐Assif, T Meshel, S Izraely, S Ben Menachem, ... The Journal of pathology 236 (1), 116-127, 2015 | 112 | 2015 |
| Fibroblast-derived IL33 facilitates breast cancer metastasis by modifying the immune microenvironment and driving type 2 immunity O Shani, T Vorobyov, L Monteran, D Lavie, N Cohen, Y Raz, G Tsarfaty, ... Cancer research 80 (23), 5317-5329, 2020 | 102 | 2020 |
